DK392789A - Konjugater af peroxiddismutase - Google Patents

Konjugater af peroxiddismutase Download PDF

Info

Publication number
DK392789A
DK392789A DK392789A DK392789A DK392789A DK 392789 A DK392789 A DK 392789A DK 392789 A DK392789 A DK 392789A DK 392789 A DK392789 A DK 392789A DK 392789 A DK392789 A DK 392789A
Authority
DK
Denmark
Prior art keywords
glycol
conjugates
peroxide dismutase
substituted
polyethylene
Prior art date
Application number
DK392789A
Other languages
English (en)
Other versions
DK392789D0 (da
DK160842B (da
DK160842C (da
Inventor
Mark Saifer
Ralph Somack
David L Williams
Original Assignee
Ddi Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ddi Pharmaceuticals filed Critical Ddi Pharmaceuticals
Publication of DK392789A publication Critical patent/DK392789A/da
Publication of DK392789D0 publication Critical patent/DK392789D0/da
Publication of DK160842B publication Critical patent/DK160842B/da
Application granted granted Critical
Publication of DK160842C publication Critical patent/DK160842C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • A61K38/446Superoxide dismutase (1.15)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/089Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0089Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
DK392789A 1987-08-03 1989-08-10 Vandoploeselige konjugater af superoxiddismutase, samt farmaceutisk praeparat indeholdende konjugatet DK160842C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US8100987A 1987-08-03 1987-08-03
US8100987 1987-08-03
PCT/US1988/002530 WO1989001033A1 (en) 1987-08-03 1988-07-29 Conjugates of superoxide dismutase
US8802530 1988-07-29

Publications (4)

Publication Number Publication Date
DK392789A true DK392789A (da) 1989-08-10
DK392789D0 DK392789D0 (da) 1989-08-10
DK160842B DK160842B (da) 1991-04-22
DK160842C DK160842C (da) 1991-10-14

Family

ID=22161332

Family Applications (1)

Application Number Title Priority Date Filing Date
DK392789A DK160842C (da) 1987-08-03 1989-08-10 Vandoploeselige konjugater af superoxiddismutase, samt farmaceutisk praeparat indeholdende konjugatet

Country Status (17)

Country Link
EP (1) EP0377613B1 (da)
JP (1) JP2515389B2 (da)
KR (1) KR920001426B1 (da)
CN (1) CN1020458C (da)
AU (1) AU608901B2 (da)
CA (1) CA1309046C (da)
DE (1) DE3876997T2 (da)
DK (1) DK160842C (da)
ES (1) ES2007536A6 (da)
HU (1) HU203783B (da)
IE (1) IE64284B1 (da)
IL (1) IL87177A (da)
NZ (1) NZ225481A (da)
PH (1) PH27225A (da)
RU (1) RU1776275C (da)
WO (1) WO1989001033A1 (da)
ZA (1) ZA885249B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0470128T4 (da) 1989-04-19 2003-12-01 Enzon Inc Aktive polyalkylenoxidcarbonater til modifikation af polypeptider
US5109118A (en) * 1989-07-06 1992-04-28 Yutaka Mizushima Modified biologically active proteins
GB8919661D0 (en) * 1989-08-31 1989-10-11 Univ Alberta Superoxide dismutase-catalase conjugates
US5772996A (en) * 1990-08-03 1998-06-30 Public Health Laboratory Service Board Pharmaceutical compositions containing superoxide dismutase from Bacillus Stearothermophilus and Bacillus Caldotenax
HUT67006A (en) * 1991-08-05 1995-01-30 Sterling Winthrop Inc Buffered composition containing mammalian superoxide-dismutase/polyethylene glycol coniugate
FR2687681B1 (fr) * 1992-02-20 1995-10-13 Transgene Sa Conjugues polyethyleneglycol-hirudine, leur procede de preparation et leur emploi pour le traitement des thromboses.
US5349001A (en) * 1993-01-19 1994-09-20 Enzon, Inc. Cyclic imide thione activated polyalkylene oxides
US5516703A (en) * 1993-08-20 1996-05-14 The University Of Utah Coating of hydrophobic surfaces to render them protein resistant while permitting covalent attachment of specific ligands
US6284503B1 (en) 1993-08-20 2001-09-04 University Of Utah Research Foundation Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces
DE69920221T2 (de) * 1998-06-23 2005-09-08 Novozymes A/S Polypeptid-polymer konjugat
US6638526B1 (en) 1998-06-23 2003-10-28 Novozymes A/S Polypeptides conjugated to copolymers of ethylene oxide and propylene oxide to reduce allergenicity
CN1315997A (zh) * 1998-07-17 2001-10-03 诺沃奇梅兹有限公司 具有改进的洗涤性能的多肽-聚合物缀合物
US8129330B2 (en) 2002-09-30 2012-03-06 Mountain View Pharmaceuticals, Inc. Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
US20040062748A1 (en) 2002-09-30 2004-04-01 Mountain View Pharmaceuticals, Inc. Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
RS20050502A (en) 2002-12-26 2007-08-03 Mountain View Pharmaceuticals Inc., Polymer conjugates of interferon- beta with enhanced biological potency
EP2336162A1 (en) 2003-05-12 2011-06-22 Affymax, Inc. Novel poly (ethylene glycol) modified erythropoietin agonists and uses thereof
CN108445106A (zh) * 2018-04-11 2018-08-24 南京明捷生物医药检测有限公司 一种药物中消泡剂聚丙二醇残留的检测方法
CN108864309B (zh) * 2018-07-26 2021-07-13 广州暨南大学医药生物技术研究开发中心有限公司 重组人sod-生长因子融合蛋白、其制备方法及其应用
CN109112119B (zh) * 2018-08-28 2022-04-26 佛山科学技术学院 经化学修饰的鸭血sod制剂的制备方法
CN117551625B (zh) * 2024-01-12 2024-03-08 山东爱维德生物科技有限公司 一种用于木立芦荟sod胶的聚乙二醇二胺-海藻酸改性sod酶及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL74177A (en) * 1984-02-03 1989-09-10 Abbott Lab Stabilized enzyme conjugate composition containing a calcium salt and a polyethylene glycol
GB8430252D0 (en) * 1984-11-30 1985-01-09 Beecham Group Plc Compounds
GB8430253D0 (en) * 1984-11-30 1985-01-09 Beecham Group Plc Compounds
JPH084504B2 (ja) * 1985-04-26 1996-01-24 味の素株式会社 安定化ス−パ−オキサイドジスムタ−ゼ

Also Published As

Publication number Publication date
DE3876997D1 (de) 1993-02-04
KR890701736A (ko) 1989-12-21
CN1031088A (zh) 1989-02-15
IL87177A0 (en) 1988-12-30
HUT52816A (en) 1990-08-28
AU2326888A (en) 1989-03-01
PH27225A (en) 1993-05-04
AU608901B2 (en) 1991-04-18
DK392789D0 (da) 1989-08-10
DK160842B (da) 1991-04-22
JP2515389B2 (ja) 1996-07-10
HU203783B (en) 1991-09-30
RU1776275C (ru) 1992-11-15
WO1989001033A1 (en) 1989-02-09
IE64284B1 (en) 1995-07-26
DE3876997T2 (de) 1993-04-29
EP0377613A1 (en) 1990-07-18
IL87177A (en) 1992-08-18
ZA885249B (en) 1989-04-26
ES2007536A6 (es) 1989-06-16
EP0377613B1 (en) 1992-12-23
IE882206L (en) 1989-02-03
JPH02504341A (ja) 1990-12-13
NZ225481A (en) 1990-11-27
KR920001426B1 (ko) 1992-02-13
CA1309046C (en) 1992-10-20
DK160842C (da) 1991-10-14
CN1020458C (zh) 1993-05-05

Similar Documents

Publication Publication Date Title
DK392789A (da) Konjugater af peroxiddismutase
FI872393A (fi) Tumoer nekrosfaktorformulation.
BE902595A (fr) Amines polymeres a empechement sterique.
ES2161444T3 (es) Poliolefinas con reologia modificada.
DE69615003D1 (de) Polyolefinzusammensetzungen und blasfolien hieraus hergestellt
KR880701564A (ko) 스타버스트 콘쥬게이트
ES2136890T3 (es) Catalizadores carbocationicos y procedimiento para utilizar dichos catalizadores.
DK0762888T3 (da) Copolymer-1 forbedringer i præparater af copolymerer
DK0510356T3 (da) Polyethylenglycolproteinkonjugater
BR0012197A (pt) Composição de poliolefina com propriedade de impacto melhoradas e artigo fabricado da mesma
ATE88898T1 (de) Cd4-polypeptidderivate.
ATE165102T1 (de) Peg-interferon-konjugate
ES2058539T3 (es) Compuesto de resina de poliacetal y miembro deslizante.
ES2105606T3 (es) Homopolimeros del propileno.
BR9903438A (pt) Fralda descartável
DE60032255D1 (de) Polymer-stabilisierte neuropeptide
IT8020294A0 (it) Basso peso molecolare. copolimeri isocianato-acrilici di
GR900100692A (el) Συνδυασμένο εμβόλιο για streptococcus ομάδας Β.
FR2769316B1 (fr) Copolymere greffe par polymerisation radicalaire en presence de radicaux stables, sa preparation et ses applications
ES2084740T3 (es) Derivados de diamino-5-triazinona y composiciones polimericas autoextinguentes que los contienen.
NO904153D0 (no) Tannpasta.
DE69125707D1 (de) Anthracyclinkonjugate
FI881528A (fi) Substituerade urinaemnen, foerfarande foer deras framstaellning och deras anvaendning i synnerhet foer foeraedling av cellulosafibrer.
ES2084591T3 (es) Composicion detergente.
FI924336A (fi) Smittaemneskomposition med sur, organisk adhesiv polymer och katjonisk ammoniumsubstituerad polymer

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK